These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 11217907

  • 21. Inhaled fluticasone dipropionate decreases levels of nitric oxide in recurrenty wheezy infants.
    Moeller A, Franklin P, Hall GL, Turner S, Straub D, Wildhaber JH, Stick SM.
    Pediatr Pulmonol; 2004 Sep; 38(3):250-5. PubMed ID: 15274106
    [Abstract] [Full Text] [Related]

  • 22. Bronchodilator reversibility, airway eosinophilia and anti-inflammatory effects of inhaled fluticasone in COPD are not related.
    Reid DW, Wen Y, Johns DP, Williams TJ, Ward C, Walters EH.
    Respirology; 2008 Nov; 13(6):799-809. PubMed ID: 18811878
    [Abstract] [Full Text] [Related]

  • 23. Fast onset of effect of budesonide/formoterol versus salmeterol/fluticasone and salbutamol in patients with chronic obstructive pulmonary disease and reversible airway obstruction.
    Lindberg A, Szalai Z, Pullerits T, Radeczky E.
    Respirology; 2007 Sep; 12(5):732-9. PubMed ID: 17875063
    [Abstract] [Full Text] [Related]

  • 24. Inhaled fluticasone reduces sputum inflammatory indices in severe bronchiectasis.
    Tsang KW, Ho PL, Lam WK, Ip MS, Chan KN, Ho CS, Ooi CC, Yuen KY.
    Am J Respir Crit Care Med; 1998 Sep; 158(3):723-7. PubMed ID: 9730996
    [Abstract] [Full Text] [Related]

  • 25. Montelukast versus fluticasone: effects on lung function, airway responsiveness and inflammation in moderate asthma.
    Kanniess F, Richter K, Böhme S, Jörres RA, Magnussen H.
    Eur Respir J; 2002 Oct; 20(4):853-8. PubMed ID: 12412675
    [Abstract] [Full Text] [Related]

  • 26. Effect of high dose inhaled steroid on cells, cytokines, and proteases in induced sputum in chronic obstructive pulmonary disease.
    Culpitt SV, Maziak W, Loukidis S, Nightingale JA, Matthews JL, Barnes PJ.
    Am J Respir Crit Care Med; 1999 Nov; 160(5 Pt 1):1635-9. PubMed ID: 10556133
    [Abstract] [Full Text] [Related]

  • 27. Bronchial nitric oxide is related to symptom relief during fluticasone treatment in COPD.
    Lehtimäki L, Kankaanranta H, Saarelainen S, Annila I, Aine T, Nieminen R, Moilanen E.
    Eur Respir J; 2010 Jan; 35(1):72-8. PubMed ID: 19574327
    [Abstract] [Full Text] [Related]

  • 28. Randomised controlled trial of inhaled corticosteroids (fluticasone propionate) in cystic fibrosis.
    Balfour-Lynn IM, Klein NJ, Dinwiddie R.
    Arch Dis Child; 1997 Aug; 77(2):124-30. PubMed ID: 9301350
    [Abstract] [Full Text] [Related]

  • 29. Effects of fluticasone on systemic markers of inflammation in chronic obstructive pulmonary disease.
    Sin DD, Lacy P, York E, Man SF.
    Am J Respir Crit Care Med; 2004 Oct 01; 170(7):760-5. PubMed ID: 15229100
    [Abstract] [Full Text] [Related]

  • 30. The interrelationship between markers of inflammation and oxidative stress in chronic obstructive pulmonary disease: modulation by inhaled steroids and antioxidant.
    Sadowska AM, van Overveld FJ, Górecka D, Zdral A, Filewska M, Demkow UA, Luyten C, Saenen E, Zielinski J, De Backer WA.
    Respir Med; 2005 Feb 01; 99(2):241-9. PubMed ID: 15715193
    [Abstract] [Full Text] [Related]

  • 31. Effect of fluticasone propionate on sputum of patients with chronic bronchitis and emphysema.
    Llewellyn-Jones CG, Harris TA, Stockley RA.
    Am J Respir Crit Care Med; 1996 Feb 01; 153(2):616-21. PubMed ID: 8564107
    [Abstract] [Full Text] [Related]

  • 32. Exhaled nitric oxide in bronchiectasis: the effects of inhaled corticosteroid therapy.
    Tsang KW, Tan KC, Ho PL, Ooi GC, Khong PL, Leung R, Mak JC, Tipoe GL, Ko C, Lam WK.
    Int J Tuberc Lung Dis; 2004 Nov 01; 8(11):1301-7. PubMed ID: 15581196
    [Abstract] [Full Text] [Related]

  • 33. Predicting corticosteroid response in chronic obstructive pulmonary disease using exhaled nitric oxide.
    Dummer JF, Epton MJ, Cowan JO, Cook JM, Condliffe R, Landhuis CE, Smith AD, Taylor DR.
    Am J Respir Crit Care Med; 2009 Nov 01; 180(9):846-52. PubMed ID: 19661244
    [Abstract] [Full Text] [Related]

  • 34. Sputum eosinophilia predicts benefit from prednisone in smokers with chronic obstructive bronchitis.
    Pizzichini E, Pizzichini MM, Gibson P, Parameswaran K, Gleich GJ, Berman L, Dolovich J, Hargreave FE.
    Am J Respir Crit Care Med; 1998 Nov 01; 158(5 Pt 1):1511-7. PubMed ID: 9817701
    [Abstract] [Full Text] [Related]

  • 35. Dissociation of lung function and airway inflammation in chronic obstructive pulmonary disease.
    Lapperre TS, Snoeck-Stroband JB, Gosman MM, Stolk J, Sont JK, Jansen DF, Kerstjens HA, Postma DS, Sterk PJ, Groningen and Leiden Universities Corticosteroids in Obstructive Lung Disease Study Group.
    Am J Respir Crit Care Med; 2004 Sep 01; 170(5):499-504. PubMed ID: 15172889
    [Abstract] [Full Text] [Related]

  • 36. Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trial.
    Brightling CE, Monteiro W, Ward R, Parker D, Morgan MD, Wardlaw AJ, Pavord ID.
    Lancet; 2000 Oct 28; 356(9240):1480-5. PubMed ID: 11081531
    [Abstract] [Full Text] [Related]

  • 37. Exhaled nitric oxide and hydrogen peroxide in patients with chronic obstructive pulmonary disease: effects of inhaled beclomethasone.
    Ferreira IM, Hazari MS, Gutierrez C, Zamel N, Chapman KR.
    Am J Respir Crit Care Med; 2001 Sep 15; 164(6):1012-5. PubMed ID: 11587988
    [Abstract] [Full Text] [Related]

  • 38. Breath profiles by electronic nose correlate with systemic markers but not ozone response.
    Biller H, Holz O, Windt H, Koch W, Müller M, Jörres RA, Krug N, Hohlfeld JM.
    Respir Med; 2011 Sep 15; 105(9):1352-63. PubMed ID: 21439804
    [Abstract] [Full Text] [Related]

  • 39. Markers of nitric oxide metabolism in sputum and exhaled air are not increased in chronic obstructive pulmonary disease.
    Rutgers SR, van der Mark TW, Coers W, Moshage H, Timens W, Kauffman HF, Koëter GH, Postma DS.
    Thorax; 1999 Jul 15; 54(7):576-80. PubMed ID: 10377200
    [Abstract] [Full Text] [Related]

  • 40. "Refractory" eosinophilic airway inflammation in severe asthma: effect of parenteral corticosteroids.
    ten Brinke A, Zwinderman AH, Sterk PJ, Rabe KF, Bel EH.
    Am J Respir Crit Care Med; 2004 Sep 15; 170(6):601-5. PubMed ID: 15215154
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.